Glyceollins, a novel class of antiestrogenic phytoalexins

Molecular and Cellular Pharmacology

Volumn 2, Issue 4, 2010, Pages 155-160

  Tilghman, Syreeta L ^a   Boué, Stephen M ^b   Burow, Matthew E ^c  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b SOUTHERN REGIONAL RESEARCH CENTER   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activated soy; Antiestrogen; Breast cancer; Estrogen receptor; Glyceollins; Glycinol; Phyto SERM; Phytoalexin; Phytoestrogen; Pterocarpan; Selective estrogen receptor modulator (SERM)

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLYCEOLLIN DERIVATIVE; GLYCEOLLIN I; GLYCEOLLIN II; GLYCEOLLIN III; NERVE GROWTH FACTOR RECEPTOR; PHYTOALEXIN; STROMAL CELL DERIVED FACTOR 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTIESTROGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; BIOSYNTHESIS; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CYCLIZATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HYDROXYLATION; IN VITRO STUDY; MOLECULAR DOCKING;

GLYCINE MAX;

EID: 78049419666     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.10.21     Document Type: Article

References (33)

1. Elghamry MI, Shihata IM. Biological Activity of Phytoestrogens III. Experimental studies on some biological properties of β-sitosterol. Planta Med 1966;14:352-7.
2. Tham DM, Gardner CD, Haskell, WL. Clinical Review 97; Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-35.
3. Magee PJ, Rowland IR Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004;91:513-31.
4. Barnes S. Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 1998;12:559-79.
5. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;50:3-23.
6. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and Risk of Breast Cancer in Asian-Americans. Cancer Epi demiol Biomarkers Prev 1996;5:901-6.
7. Fournier DB, Erdman JW, Gordon GB. Soy, its components, and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiol Biomarkers Prev 1998;7:1055-65.
8. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-1690.
9. Adlercreutz H. Phytoestrogens: Epidemiology and a possible role in cancer protection. In: McLachlan, J.A., Korach, K.S. (eds) Estrogens in the Environment, III: global health implications. Environ Health Perspect. 1995;103: Suppl. 7:103-12.
10. Murkies AL, Wilcox G, Davis SR. Clinical review 92: Phytoestrogens. J Clin Endocrinol. Metab 1998;83:297-303.
11. Cline JM, Hughes CL. Phytochemicals for the prevention of breast and endometrial cancer. In: Foon, K.A. and Muss, H.B. (eds) Biological and hormonal therapies of cancer. 1998;107-34.
12. Humfrey CDN. Phytoestrogens and human health effects: weighing up the current evidence. Natural Toxins 1998;6:51-9.
13. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-estrogens: where are we now? Brit J of Nutr 1998;79:393-406.
14. Dakora, FD, Phillips DA. Diverse functions of isoflavonoids in legumes transcend anti-microbial difinitions of phytoalexins. Physiol Molecular Plant Physiol 1996;49:1-20.
15. Darvill AG and Albersheim P. Phytoalexins and their elcitors- a defense against microbial infection in plants. Ann Rev Plant Physiol 1994;35:243-75.
16. Graham TL, Kim JE, Graham MY. Role of constitutive isoflavone conjugates in the accumulation of glyceollin in soybean infected with Phytophthora megasperma. Mol Plant-Microbe Interactions 1990;3:157-66.
17. Paxton JD. Biosynthesis and accumulation of legume phytoalexins, in Mycotoxins and Phytoalexins, R.P. Sharma and D.K Salunkhe editors, CRC Press, Boca Raton, FL. 1991.
18. Rivera-Vargas LI, Schmitthenner AF, Graham TL. Soybean flavonoid effects on and metabolism by Phytophthora sojae. Phytochem 1993; 32:851-7.
19. Graham TL, Graham MY. Glyceollin elicitors induce major but distinctly different shifts in isoflavonoid metabolism in proximal and distal soybean cell populations. Mol. Plant-Microbe Interactions 1991;4:60-8.
20. Kim HJ, Suh HJ, Kim JH, et al. Estrogenic activity of glyceollins isolated from soybean elicited with Aspergillus sojae. J Med Food 2010;13:382-90.
21. Burow ME, Boué SM, Collins-Burow BM, et al. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor α and β. J Endocrinol 2001;86:1750-58.
22. Salvo VA, Boué SM, Fonseca JP, et al. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 2006;2:7159-64.
23. Wood CE, Clarkson TB, Appt SE, et al. Effects of soybean Glyceollins and estradiol on postmenopausal female monkeys. Nutr and Cancer 2006;56:67-75.
24. Boué, S.M., Carter, C., Ehrlich, K. and Cleveland, T. Induction of the soybean phytoalexins coumestrol and glyceollin by Aspergillus. J Agric Food Chem 2000;48:2167-2172.
25. Bouë SM, Tilghman SL, Elliott S, et al. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology 2009;150:2446-53.
26. Banks SW, Dewick PM. Biosynthesis of glyceollins I, II, and III in soybean. Phytochem 1993;22:2729-33.
27. Payton-Stewart F, Schoene NW, Kim YS, et al. Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Mol Carcinog 2009;48:862-71.
28. Zimmermann MC, Tilghman SL, Boué SM, et al. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther 2010;332:35-45.
29. Khupse RS, Erhardt PW. Total syntheses of racemic, natural (-) and unnatural (+) glyceollin I. Org Lett 2008;10:5007-10.
30. Korach KS, Chae K, Gibson M, Curtis S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Steroids 1991;56:263-70.
31. Korach KS, Chae K, Levy LA, Duax WL, Sarver PJ. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site. J Biol Chem 1989;264:5642-7.
32. Korach KS, Fox-Davies C, Quarmby VE, Swaisgood MH. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses. J Biol Chem 1985;260:15420-6.
33. Payton-Stewart F, Khupse RS, Boué SM, Elliott S, Zimmermann MC, Skripnikova EV, Ashe H, Tilghman SL, Beckman BS, Cleveland TE, McLachlan JA, Bhatnagar D, Wiese TE, Erhardt P, Burow ME. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids 2010;75:870-8.